Kimberly Mathisen, Board director of Aker BioMarine ASA, has today purchased 4000 shares in Aker BioMarine ASA at an average price of NOK 52 per share. Following the transaction, Mathisen controls 8000 shares in Aker BioMarine ASA.

Please see attached primary insider notification form pursuant to the requirements of the Market Abuse Regulation (“MAR”).

This information is subject to the disclosure requirements pursuant to MAR Article 19 and Section 5-12 of the Norwegian Securities Trading Act.

About Aker BioMarine:
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.